|
1
|
Williams RT, Wu L, Carbonaro-Hall DA, Tolo
VT and Hall FL: Identification of a novel cyclin-like protein in
human tumor cells. J Biol Chem. 268:8871–8880. 1993.PubMed/NCBI
|
|
2
|
Richardson HE, Stueland CS, Thomas J,
Russell P and Reed SI: Human cDNAs encoding homologs of the small
p34Cdc28/Cdc2-associated protein of Saccharomyces cerevisiae and
Schizosaccharomyces pombe. Genes Dev. 4:1332–1344. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Demetrick DJ, Zhang H and Beach DH:
Chromosomal mapping of the human genes CKS1 to 8q21 and CKS2 to
9q22. Cytogenet Cell Genet. 73:250–254. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Urbanowicz-Kachnowicz I, Baghdassarian N,
Nakache C, Gracia D, Mekki Y, Bryon PA and Ffrench M: ckshs
expression is linked to cell proliferation in normal and malignant
human lymphoid cells. Int J Cancer. 82:98–104. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ganoth D, Bornstein G, Ko TK, Larsen B,
Tyers M, Pagano M and Hershko A: The cell-cycle regulatory protein
Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27.
Nat Cell Biol. 3:321–324. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Spruck CH, de Miguel MP, Smith AP, Ryan A,
Stein P, Schultz RM, Lincoln AJ, Donovan PJ and Reed SI:
Requirement of Cks2 for the first metaphase/anaphase transition of
mammalian meiosis. Science. 300:647–650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rother K, Dengl M, Lorenz J, Tschöp K,
Kirschner R, Mössner J and Engeland K: Gene expression of
cyclin-dependent kinase subunit Cks2 is repressed by the tumor
suppressor p53 but not by the related proteins p63 or p73. FEBS
Lett. 581:1166–1172. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martinsson-Ahlzén H-S, Liberal V,
Grünenfelder B, Chaves SR, Spruck CH and Reed SI: Cyclin-dependent
kinase-associated proteins Cks1 and Cks2 are essential during early
embryogenesis and for cell cycle progression in somatic cells. Mol
Cell Biol. 28:5698–5709. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen DY, Fang ZX, You P, Liu PG, Wang F,
Huang CL, Yao XB, Chen ZX and Zhang ZY: Clinical significance and
expression of cyclin kinase subunits 1 and 2 in hepatocellular
carcinoma. Liver Int. 30:119–125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang JJ, Fang ZX, Ye HM, You P, Cai MJ,
Duan HB, Wang F and Zhang ZY: Clinical significance of
overexpressed cyclin-dependent kinase subunits 1 and 2 in
esophageal carcinoma. Dis Esophagus. 26:729–736. 2013.PubMed/NCBI
|
|
11
|
Kita Y, Nishizono Y, Okumura H, et al:
Clinical and biological impact of cyclin-dependent kinase subunit 2
in esophageal squamous cell carcinoma. Oncol Rep. 31:1986–1992.
2014.PubMed/NCBI
|
|
12
|
Tanaka F, Matsuzaki S, Mimori K, Kita Y,
Inoue H and Mori M: Clinicopathological and biological significance
of CDC28 protein kinase regulatory subunit 2 overexpression in
human gastric cancer. Int J Oncol. 39:361–372. 2011.PubMed/NCBI
|
|
13
|
Notterman DA, Alon U, Sierk AJ and Levine
AJ: Transcriptional gene expression profiles of colorectal adenoma,
adenocarcinoma, and normal tissue examined by oligonucleotide
arrays. Cancer Res. 61:3124–3130. 2001.PubMed/NCBI
|
|
14
|
Jung Y, Lee S, Choi HS, et al: Clinical
validation of colorectal cancer biomarkers identified from
bioinformatics analysis of public expression data. Clin Cancer Res.
17:700–709. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu M, Zhong M and Qiao Z: Expression and
clinical significance of cyclin kinase subunit 2 in colorectal
cancer. Oncol Lett. 6:777–780. 2013.PubMed/NCBI
|
|
16
|
Li M, Lin Y-M, Hasegawa S, et al: Genes
associated with liver metastasis of colon cancer, identified by
genome-wide cDNA microarray. Int J Oncol. 24:305–312.
2004.PubMed/NCBI
|
|
17
|
Kawakami K, Enokida H, Tachiwada T,
Gotanda T, Tsuneyoshi K, Kubo H, Nishiyama K, Takiguchi M, Nakagawa
M and Seki N: Identification of differentially expressed genes in
human bladder cancer through genome-wide gene expression profiling.
Oncol Rep. 16:521–531. 2006.PubMed/NCBI
|
|
18
|
Chen R, Feng C and Xu Y: Cyclin-dependent
kinase-associated protein Cks2 is associated with bladder cancer
progression. J Int Med Res. 39:533–540. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scrideli CA, Carlotti CG Jr, Okamoto OK,
et al: Gene expression profile analysis of primary glioblastomas
and non-neoplastic brain tissue: Identification of potential target
genes by oligonucleotide microarray and real-time quantitative PCR.
J Neurooncol. 88:281–291. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rickman DS, Bobek MP, Misek DE, Kuick R,
Blaivas M, Kurnit DM, Taylor J and Hanash SM: Distinctive molecular
profiles of high-grade and low-grade gliomas based on
oligonucleotide microarray analysis. Cancer Res. 61:6885–6891.
2001.PubMed/NCBI
|
|
21
|
Haaber J, Abildgaard N, Knudsen LM, Dahl
IM, Lodahl M, Thomassen M, Kerndrup GB and Rasmussen T: Myeloma
cell expression of 10 candidate genes for osteolytic bone disease.
Only overexpression of DKK1 correlates with clinical bone
involvement at diagnosis. Br J Haematol. 140:25–35. 2008.PubMed/NCBI
|
|
22
|
Williams MD, Zhang L, Elliott DD, Perrier
ND, Lozano G, Clayman GL and El-Naggar AK: Differential gene
expression profiling of aggressive and nonaggressive follicular
carcinomas. Hum Pathol. 42:1213–1220. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lan Y, Zhang Y, Wang J, Lin C, Ittmann MM
and Wang F: Aberrant expression of Cks1 and Cks2 contributes to
prostate tumorigenesis by promoting proliferation and inhibiting
programmed cell death. Int J Cancer. 123:543–551. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
de Wit NJ, Rijntjes J, Diepstra JH, van
Kuppevelt TH, Weidle UH, Ruiter DJ and van Muijen GN: Analysis of
differential gene expression in human melanocytic tumour lesions by
custom made oligonucleotide arrays. Br J Cancer. 92:2249–2261.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wong YF, Cheung TH, Tsao GS, et al:
Genome-wide gene expression profiling of cervical cancer in Hong
Kong women by oligonucleotide microarray. Int J Cancer.
118:2461–2469. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ni RS, Shen X, Qian X, Yu C, Wu H and Gao
X: Detection of differentially expressed genes and association with
clinicopathological features in laryngeal squamous cell carcinoma.
Oncol Lett. 4:1354–1360. 2012.PubMed/NCBI
|
|
27
|
Menghi F, Orzan FN, Eoli M, et al: DNA
microarray analysis identifies CKS2 and LEPR as potential markers
of meningioma recurrence. Oncologist. 16:1440–1450. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kang MA, Kim JT, Kim JH, Kim SY, Kim YH,
Yeom YI, Lee Y and Lee HG: Upregulation of the cycline kinase
subunit CKS2 increases cell proliferation rate in gastric cancer. J
Cancer Res Clin Oncol. 135:761–769. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shen DY, Zhan YH, Wang QM, Rui G and Zhang
ZM: Oncogenic potential of cyclin kinase subunit-2 in
cholangiocarcinoma. Liver Int. 33:137–148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gendreau KM and Whalen GF: What can we
learn from the phenomenon of preferential lymph node metastasis in
carcinoma? J Surg Oncol. 70:199–204. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lyng H, Brøvig RS, Svendsrud DH, Holm R,
Kaalhus O, Knutstad K, Oksefjell H, Sundfør K, Kristensen GB and
Stokke T: Gene expressions and copy numbers associated with
metastatic phenotypes of uterine cervical cancer. BMC Genomics.
7:2682006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin HM, Chatterjee A, Lin YH, Anjomshoaa
A, Fukuzawa R, McCall JL and Reeve AE: Genome wide expression
profiling identifies genes associated with colorectal liver
metastasis. Oncol Rep. 17:1541–1549. 2007.PubMed/NCBI
|
|
33
|
Dorée M and Hunt T: From Cdc2 to Cdk1:
when did the cell cycle kinase join its cyclin partner? J Cell Sci.
115:2461–2464. 2002.PubMed/NCBI
|
|
34
|
Vassilev LT, Tovar C, Chen S, Knezevic D,
Zhao X, Sun H, Heimbrook DC and Chen L: Selective small-molecule
inhibitor reveals critical mitotic functions of human CDK1. Proc
Natl Acad Sci USA. 103:10660–10665. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
LV M, Zhang X, Li M, Chen Q, Ye M, Liang
W, Ding L, Cai H, Fu D and Lv Z: miR-26a and its target CKS2
modulate cell growth and tumorigenesis of papillary thyroid
carcinoma. PLoS ONE. 8:e675912013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kohno K, Izumi H, Uchiumi T, Ashizuka M
and Kuwano M: The pleiotropic functions of the Y-box-binding
protein, YB-1. BioEssays. 25:691–698. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu YN, Yip GW, Tan PH, Thike AA, Matsumoto
K, Tsujimoto M and Bay BH: Y-box binding protein 1 is up-regulated
in proliferative breast cancer and its inhibition deregulates the
cell cycle. Int J Oncol. 37:483–492. 2010.PubMed/NCBI
|
